ANBT
WST icon

American National Bank & Trust’s West Pharmaceutical WST Stock Holding History

American National Bank & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12
Closed -$3.93K – 661
2024
Q4 		$3.93K Hold
12
– – ﹤0.01% 471
2024
Q3 		$3.6K Buy
+12
New +$3.67K ﹤0.01% 438
2022
Q3 		– Sell
-81
Closed -$24K – 611
2022
Q2 		$24K Sell
81
-17
-17% -$5.53K 0.01% 236
2022
Q1 		$40K Buy
98
+35
+56% +$13.7K 0.01% 210
2021
Q4 		$30K Buy
63
+5
+9% +$2.15K 0.01% 226
2021
Q3 		$25K Buy
58
+15
+35% +$6.32K 0.01% 210
2021
Q2 		$15K Buy
43
+27
+169% +$8.92K ﹤0.01% 212
2021
Q1 		$5K Buy
+16
New +$4.58K ﹤0.01% 235

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

American National Bank & Trust's WST Position: Q1 2025 in Review

American National Bank & Trust sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 12 shares — an estimated $3.93K sold.

American National Bank & Trust first reported a position in WST in Q1 2021 and held it in 8 quarters. The position peaked at $40K in Q1 2022. 713 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • American National Bank & Trust reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • American National Bank & Trust sold 12 West Pharmaceutical shares in Q1 2025, an estimated $3.93K.
  • American National Bank & Trust first reported a position in West Pharmaceutical in Q1 2021 and held it in 8 quarters.
  • American National Bank & Trust's West Pharmaceutical position peaked at $40K in Q1 2022.
  • 713 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on American National Bank & Trust's 13F filing for Q1 2025, filed 9 Apr 2025.